Molecular circuits of resolution in airway inflammation

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1386-1399

  Carlo, Troy ^a   Levy, Bruce D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Airway inflammation; Anti inflammatory; Asthma; Lipoxin; Mediator; Polyunsaturated fatty acid; Protectin; Resolution; Resolvin

Indexed keywords

15 HYDROPEROXYARACHIDONIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CD59 ANTIGEN; CYCLOOXYGENASE 2 INHIBITOR; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOXIN A; LIPOXIN B; MARESIN DERIVATIVE; MEVINOLIN; PIOGLITAZONE; POLYUNSATURATED FATTY ACID; RESOLVIN 1; SERUM AMYLOID A; UNCLASSIFIED DRUG; LIPOXIN;

ACUTE LUNG INJURY; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; BACTERIAL PNEUMONIA; BIOSYNTHESIS; COMPETITIVE INHIBITION; HUMAN; IN VIVO STUDY; LUNG FIBROSIS; MOLECULAR DYNAMICS; NONHUMAN; PNEUMONIA; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; METABOLISM;

ANTIGENS, CD59; DOCOSAHEXAENOIC ACIDS; HUMANS; LIPOXINS; PNEUMONIA;

EID: 77955856343     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.143     Document Type: Review

References (101)

1. Nathan, C. and Ding, A. Nonresolving inflammation. Cell 140, 871-882.
2. Shelhamer, J.H., Levine, S.J., Wu, T., Jacoby, D.B., Kaliner, M.A., and Rennard, S.I. (1995) NIH conference. Airway inflammation. Ann. Intern. Med. 123, 288-304.
3. Farver, C.F. (2008) Bacterial diseases. In Pulmonary Pathology. Zander, D.S. and Farvarer, C.F., Eds. Churchill Livingstone Elsevier, Philadelphia. pp. 167-203.
4. Ware, L.B. and Matthay, M.A. (2000) The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334-1349.
5. Busse, W.W. and Lemanske, R.F., Jr. (2001) Asthma. N. Engl. J. Med. 344, 350-362.
6. Moorman, J.E., Rudd, R.A., Johnson, C.A., King, M., Minor, P., Bailey, C., Scalia, M.R., Akinbami, L.J.; Centers for Disease Control and Prevention (2007) National surveillance for asthma - United States, 1980-2004. MMWR Surveill. Summ. 56, 1-54.
7. Matute-Bello, G., Liles, W.C., Radella, F., 2nd, Steinberg, K.P., Ruzinski, J.T., Hudson, L.D., and Martin, T.R. (2000) Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit. Care Med. 28, 1-7.
8. Haslett, C. (1992) Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin. Sci. 83, 639-648.
9. Bousquet, J., Jeffery, P.K., Busse, W.W., Johnson, M., and Vignola, A.M. (2000) Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1720-1745.
10. Serhan, C.N. and Chiang, N. (2008) Endogenous proresolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153(Suppl 1), S200-215.
11. Serhan, C.N. (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137.
12. Romano, M. (2010) Lipoxin and aspirin-triggered lipoxins. TheScientificWorldJOURNAL 10, 1048-1064.
13. Levy, B.D. (2005) Lipoxins and lipoxin analogs in asthma. Prostaglandins Leukot. Essent. Fatty Acids 73, 231-237.
14. Vachier, I., Bonnans, C., Chavis, C., Farce, M., Godard, P., Bousquet, J., and Chanez, P. (2005) Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J. Allergy Clin. Immunol. 115, 55-60.
15. Birnbaum, Y., Ye, Y., Lin, Y., Freeberg, S.Y., Nishi, S.P., Martinez, J.D., Huang, M.H., Uretsky, B.F., and Perez-Polo, J.R. (2006) Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation 114, 929-935.
16. Ye, Y., Lin, Y., Perez-Polo, J.R., Uretsky, B.F., Ye, Z., Tieu, B.C., and Birnbaum, Y. (2008) Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production. J. Immunol. 181, 3515-3523.
17. Planaguma, A., Pfeffer, M.A., Rubin, G., Croze, R., Uddin, M., Serhan, C.N., and Levy, B.D. (2010) Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A(4). Mucosal Immunol. 3, 270-279.
18. Chiang, N., Serhan, C.N., Dahlen, S.E., Drazen, J.M., Hay, D.W., Rovati, G.E., Shimizu, T., Yokomizo, T., and Brink, C. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487.
19. Perretti, M., Chiang, N., La, M., Fierro, I.M., Marullo, S., Getting, S.J., Solito, E., and Serhan, C.N. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8, 1296-1302.
20. Bonnans, C., Fukunaga, K., Levy, M.A., and Levy, B.D. (2006) Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am. J. Pathol. 168, 1064-1072.
21. Fiore, S., Maddox, J.F., Perez, H.D., and Serhan, C.N. (1994) Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180, 253-260.
22. Maddox, J.F., Hachicha, M., Takano, T., Petasis, N.A., Fokin, V.V., and Serhan, C.N. (1997) Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272, 6972-6978.
23. Gronert, K., Gewirtz, A., Madara, J.L., and Serhan, C.N. (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187, 1285-1294.
24. Gronert, K., Martinsson-Niskanen, T., Ravasi, S., Chiang, N., and Serhan, C.N. (2001) Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am. J. Pathol. 158, 3-9.
25. Schaldach, C.M., Riby, J., and Bjeldanes, L.F. (1999) Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38, 7594-7600.
26. Bandeira-Melo, C., Bozza, P.T., Diaz, B.L., Cordeiro, R.S., Jose, P.J., Martins, M.A., and Serhan, C.N. (2000) Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 164, 2267-2271.
27. Levy, B.D., De Sanctis, G.T., Devchand, P.R., Kim, E., Ackerman, K., Schmidt, B.A., Szczeklik, W., Drazen, J.M., and Serhan, C.N. (2002) Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 8, 1018-1023.
28. Colgan, S.P., Serhan, C.N., Parkos, C.A., Delp-Archer, C., and Madara, J.L. (1993) Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92, 75-82.
29. Soyombo, O., Spur, B.W., and Lee, T.H. (1994) Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49, 230-234.
30. Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., and Brady, H.R. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663-1667.
31. Ohira, T., Bannenberg, G., Arita, M., Takahashi, M., Ge, Q., Van Dyke, T.E., Stahl, G.L., Serhan, C.N., and Badwey, J.A. (2004) A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils. J. Immunol. 173, 2091-2098.
32. Starosta, V., Pazdrak, K., Boldogh, I., Svider, T., and Kurosky, A. (2008) Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes. J. Immunol. 181, 8688-8699.
33. El Kebir, D., Jozsef, L., Khreiss, T., Pan, W., Petasis, N.A., Serhan, C.N., and Filep, J.G. (2007) Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 179, 616-622.
34. Perretti, M. and D'Acquisto, F. (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9, 62-70.
35. Levy, B.D., Fokin, V.V., Clark, J.M., Wakelam, M.J., Petasis, N.A., and Serhan, C.N. (1999) Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4. FASEB J. 13, 903-911.
36. Levy, B.D., Petasis, N.A., and Serhan, C.N. (1997) Polyisoprenyl phosphates in intracellular signalling. Nature 389, 985-990.
37. Bonnans, C., Fukunaga, K., Keledjian, R., Petasis, N.A., and Levy, B.D. (2006) Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury. J. Exp. Med. 203, 857-863.
38. Levy, B.D., Hickey, L., Morris, A.J., Larvie, M., Keledjian, R., Petasis, N.A., Bannenberg, G., and Serhan, C.N. (2005) Novel polyisoprenyl phosphates block phospholipase D and human neutrophil activation in vitro and murine peritoneal inflammation in vivo. Br. J. Pharmacol. 146, 344-351.
39. Fukunaga, K., Arita, M., Takahashi, M., Morris, A.J., Pfeffer, M., and Levy, B.D. (2006) Identification and functional characterization of a presqualene diphosphate phosphatase. J. Biol. Chem. 281, 9490-9497.
40. Carlo, T., Petasis, N.A., and Levy, B.D. (2009) Activation of polyisoprenyl diphosphate phosphatase 1 remodels cellular presqualene diphosphate. Biochemistry 48, 2997-3004.
41. Gewirtz, A.T., Fokin, V.V., Petasis, N.A., Serhan, C.N., and Madara, J.L. (1999) LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. Am. J. Physiol. 276, C988-994.
42. Serhan, C.N., Maddox, J.F., Petasis, N.A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H.R., Colgan, S.P., and Madara, J.L. (1995) Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34, 14609-14615.
43. Maddox, J.F. and Serhan, C.N. (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183, 137-146.
44. Schwab, J.M., Chiang, N., Arita, M., and Serhan, C.N. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874.
45. Fierro, I.M., Kutok, J.L., and Serhan, C.N. (2002) Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered- 15R-lipoxin A(4) and lipoxin A(4). J. Pharmacol. Exp. Ther. 300, 385-392.
46. Sodin-Semrl, S., Taddeo, B., Tseng, D., Varga, J., and Fiore, S. (2000) Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164, 2660-2666.
47. Parameswaran, K., Radford, K., Fanat, A., Stephen, J., Bonnans, C., Levy, B.D., Janssen, L.J., and Cox, P.G. (2007) Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. Am. J. Respir. Cell Mol. Biol. 37, 240-247.
48. Levy, B.D., Lukacs, N.W., Berlin, A.A., Schmidt, B., Guilford, W.J., Serhan, C.N., and Parkinson, J.F. (2007) Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J. 21, 3877-3884.
49. Haworth, O., Cernadas, M., Yang, R., Serhan, C.N., and Levy, B.D. (2008) Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9, 873-879.
50. Kolls, J.K., Kanaly, S.T., and Ramsay, A.J. (2003) Interleukin-17: an emerging role in lung inflammation. Am. J. Respir. Cell Mol. Biol. 28, 9-11.
51. Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H.B., Gray, M., D'Acquisto, F., Buckingham, J.C., Perretti, M., and Flower, R.J. (2010) Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. 184, 2611-2619.
52. Martins, V., Valenca, S.S., Farias-Filho, F.A., Molinaro, R., Simoes, R.L., Ferreira, T.P., e Silva, P.M., Hogaboam, C.M., Kunkel, S.L., Fierro, I.M., Canetti, C., and Benjamim, C.F. (2009) ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. J. Immunol. 182, 5374-5381.
53. Sato, Y., Kitasato, H., Murakami, Y., Hashimoto, A., Endo, H., Kondo, H., Inoue, M., and Hayashi, I. (2004) Downregulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo. Biomed. Pharmacother. 58, 381-387.
54. Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L.E., and Levy, B.D. (2005) Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J. Immunol. 174, 5033-5039.
55. El Kebir, D., Jozsef, L., Pan, W., Wang, L., Petasis, N.A., Serhan, C.N., and Filep, J.G. (2009) 15-Epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 180, 311-319.
56. Rossi, A.G., Sawatzky, D.A., Walker, A., Ward, C., Sheldrake, T.A., Riley, N.A., Caldicott, A., Martinez-Losa, M., Walker, T.R., Duffin, R., Gray, M., Crescenzi, E., Martin, M.C., Brady, H.J., Savill, J.S., Dransfield, I., and Haslett, C. (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12, 1056-1064.
57. Kim, D.Y., Ryu, S.Y., Lim, J.E., Lee, Y.S., and Ro, J.Y. (2007) Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur. J. Pharmacol. 557, 76-86.
58. McKay, A., Leung, B.P., McInnes, I.B., Thomson, N.C., and Liew, F.Y. (2004) A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J. Immunol. 172, 2903-2908.
59. Zeki, A.A., Franzi, L., Last, J., and Kenyon, N.J. (2009) Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am. J. Respir. Crit. Care Med. 180, 731-740.
60. Lee, T.H., Crea, A.E., Gant, V., Spur, B.W., Marron, B.E., Nicolaou, K.C., Reardon, E., Brezinski, M., and Serhan, C.N. (1990) Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am. Rev. Respir. Dis. 141, 1453-1458.
61. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K., and Serhan, C.N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612-619.
62. Levy, B.D., Bonnans, C., Silverman, E.S., Palmer, L.J., Marigowda, G., and Israel, E. (2005) Diminished lipoxin biosynthesis in severe asthma. Am. J. Respir. Crit. Care Med. 172, 824-830.
63. Planaguma, A., Kazani, S., Marigowda, G., Haworth, O., Mariani, T.J., Israel, E., Bleecker, E.R., Curran-Everett, D., Erzurum, S.C., Calhoun, W.J., Castro, M., Chung, K.F., Gaston, B., Jarjour, N.N., Busse, W.W., Wenzel, S.E., and Levy, B.D. (2008) Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am. J. Respir. Crit. Care Med. 178, 574-582.
64. Celik, G.E., Erkekol, F.O., Misirligil, Z., and Melli, M. (2007) Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. Clin. Exp. Allergy 37, 1494-1501.
65. Farooque, S.P. and Lee, T.H. (2009) Aspirin-sensitive respiratory disease. Annu. Rev. Physiol. 71, 465-487.
66. Sanak, M., Levy, B.D., Clish, C.B., Chiang, N., Gronert, K., Mastalerz, L., Serhan, C.N., and Szczeklik, A. (2000) Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur. Respir. J. 16, 44-49.
67. Kowal-Bielecka, O., Kowal, K., Distler, O., Rojewska, J., Bodzenta-Lukaszyk, A., Michel, B.A., Gay, R.E., Gay, S., and Sierakowski, S. (2005) Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis Rheum. 52, 3783-3791.
68. Karp, C.L., Flick, L.M., Yang, R., Uddin, J., and Petasis, N.A. (2005) Cystic fibrosis and lipoxins. Prostaglandins Leukot. Essent. Fatty Acids 73, 263-270.
69. Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N., and Gronert, K. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204.
70. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G., and Moussignac, R.L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037.
71. Sun, Y.P., Oh, S.F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S.P., Petasis, N.A., and Serhan, C.N. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 9323-9334.
72. Seki, H., Sasaki, T., Ueda, T., and Arita, M. (2010) Resolvins as regulators of the immune system. TheScientificWorldJOURNAL 10, 818-831.
73. Arita, M., Ohira, T., Sun, Y.P., Elangovan, S., Chiang, N., and Serhan, C.N. (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178, 3912-3917.
74. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A., and Serhan, C.N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722.
75. Vermi, W., Riboldi, E., Wittamer, V., Gentili, F., Luini, W., Marrelli, S., Vecchi, A., Franssen, J.D., Communi, D., Massardi, L., Sironi, M., Mantovani, A., Parmentier, M., Facchetti, F., and Sozzani, S. (2005) Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201, 509-515.
76. Campbell, E.L., Louis, N.A., Tomassetti, S.E., Canny, G.O., Arita, M., Serhan, C.N., and Colgan, S.P. (2007) Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 21, 3162-3170. (Pubitemid 47565535)
77. Ariel, A., Fredman, G., Sun, Y.P., Kantarci, A., Van Dyke, T.E., Luster, A.D., and Serhan, C.N. (2006) Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat. Immunol. 7, 1209-1216.
78. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.H., Yang, R., Petasis, N.A., and Serhan, C.N. (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U. S. A. 107, 1660-1665.
79. Kasuga, K., Yang, R., Porter, T.F., Agrawal, N., Petasis, N.A., Irimia, D., Toner, M., and Serhan, C.N. (2008) Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181, 8677-8687.
80. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Kawata, T., Shimizu, Y., Okajima, F., Dobashi, K., and Mori, M. (2008) Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem. Biophys. Res. Commun. 367, 509-515.
81. Seki, H., Fukunaga, K., Arita, M., Arai, H., Nakanishi, H., Taguchi, R., Miyasho, T., Takamiya, R., Asano, K., Ishizaka, A., Takeda, J., and Levy, B.D. (2010) The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol. 184, 836-843.
82. Arita, M., Ohira, T., Sun, Y.P., Elangovan, S., Chiang, N., and Serhan, C.N. (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178, 3912-3917.
83. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A., and Serhan, C.N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722.
84. Cash, J.L., Hart, R., Russ, A., Dixon, J.P., Colledge, W.H., Doran, J., Hendrick, A.G., Carlton, M.B., and Greaves, D.R. (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767-775.
85. Campbell, E.L., Louis, N.A., Tomassetti, S.E., Canny, G.O., Arita, M., Serhan, C.N., and Colgan, S.P. (2007) Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 21, 3162-3170. (Pubitemid 47565535)
86. Hasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C.N., and Van Dyke, T.E. (2007) Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J. Immunol. 179, 7021-7029.
87. Spite, M., Norling, L.V., Summers, L., Yang, R., Cooper, D., Petasis, N.A., Flower, R.J., Perretti, M., and Serhan, C.N. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291.
88. Mayer, K., Kiessling, A., Ott, J., Schaefer, M.B., Hecker, M., Henneke, I., Schulz, R., Gunther, A., Wang, J., Wu, L., Roth, J., Seeger, W., and Kang, J.X. (2009) Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am. J. Respir. Crit. Care Med. 179, 474-483.
89. Tiesset, H., Pierre, M., Desseyn, J.L., Guery, B., Beermann, C., Galabert, C., Gottrand, F., and Husson, M.O. (2009) Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J. Nutr. 139, 82-89.
90. Freedman, S.D., Blanco, P.G., Zaman, M.M., Shea, J.C., Ollero, M., Hopper, I.K., Weed, D.A., Gelrud, A., Regan, M.M., Laposata, M., Alvarez, J.G., and O'Sullivan, B.P. (2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. N. Engl. J. Med. 350, 560-569.
91. Pacht, E.R., DeMichele, S.J., Nelson, J.L., Hart, J., Wennberg, A.K., and Gadek, J.E. (2003) Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit. Care Med. 31, 491-500.
92. Singer, P., Theilla, M., Fisher, H., Gibstein, L., Grozovski, E., and Cohen, J. (2006) Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit. Care Med. 34, 1033-1038. [Erratum appears in Crit. Care Med. (2006) 34(6), 1861.]
93. Merchant, A.T., Curhan, G.C., Rimm, E.B., Willett, W.C., and Fawzi, W.W. (2005) Intake of n-6 and n-3 fatty acids and fish and risk of community-acquired pneumonia in US men. Am. J. Clin. Nutr. 82, 668-674.
94. Hong, S., Gronert, K., Devchand, P.R., Moussignac, R.L., and Serhan, C.N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in antiinflammation. J. Biol. Chem. 278, 14677-14687.
95. Serhan, C.N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S.P., and Petasis, N.A. (2006) Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848-1859. [Erratum appears in J. Immunol. (2006) 176(6), 3843.]
96. Marcheselli, V.L., Mukherjee, P.K., Arita, M., Hong, S., Antony, R., Sheets, K., Winkler, J.W., Petasis, N.A., Serhan, C.N., and Bazan, N.G. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 82, 27-34.
97. Levy, B.D., Kohli, P., Gotlinger, K., Haworth, O., Hong, S., Kazani, S., Israel, E., Haley, K.J., and Serhan, C.N. (2007) Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178, 496-502.
98. Serhan, C.N., Yang, R., Martinod, K., Kasuga, K., Pillai, P.S., Porter, T.F., Oh, S.F., and Spite, M. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 15-23.
99. Christie, P.E., Spur, B.W., and Lee, T.H. (1992) The effects of lipoxin A4 on airway responses in asthmatic subjects. Am. Rev. Respir. Dis. 145, 1281-1284.
100. Tahan, F., Saraymen, R., and Gumus, H. (2008) The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma. J. Asthma 45, 161-164.
101. Karp, C.L., Flick, L.M., Park, K.W., Softic, S., Greer, T.M., Keledjian, R., Yang, R., Uddin, J., Guggino, W.B., Atabani, S.F., Belkaid, Y., Xu, Y., Whitsett, J.A., Accurso, F.J., Wills-Karp, M., and Petasis, N.A. (2004) Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat. Immunol. 5, 388-392.